Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

CBLL

Ceribell Inc

Dec 12 • 04:00PM ET

20.93

+0.52 2.55 %

Healthcare • Medical Devices • USA • NASD

Held by: IWM VTI IWO VXF SCHA LFSC VTWO IWC FFSM VHT

Index	RUT	P/E	-	EPS (ttm)	-1.45	Insider Own	40.42%	Shs Outstand	37.05M	Perf Week	6.14%
Market Cap	776.41M	Forward P/E	-	EPS next Y	-1.46	Insider Trans	-1.87%	Shs Float	22.28M	Perf Month	62.88%
Enterprise Value	629.21M	PEG	-	EPS next Q	-0.41	Inst Own	53.14%	Short Float	6.55%	Perf Quarter	75.15%
Income	-52.46M	P/S	9.38	EPS this Y	55.57%	Inst Trans	0.97%	Short Ratio	3.80	Perf Half Y	21.19%
Sales	82.81M	P/B	4.73	EPS next Y	3.13%	ROA	-42.55%	Short Interest	1.46M	Perf YTD	-19.13%
Book/sh	4.43	P/C	4.61	EPS next 5Y	33.65%	ROE	-59.78%	52W High	32.75 -36.09%	Perf Year	-29.35%
Cash/sh	4.54	P/FCF	-	EPS past 3/5Y	-1.63% -	ROIC	-28.47%	52W Low	10.01 109.09%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	58.89% -	Gross Margin	87.99%	Volatility	6.80% 6.02%	Perf 5Y	-
Dividend TTM	-	EV/Sales	7.60	EPS Y/Y TTM	-	Oper. Margin	-68.46%	ATR (14)	1.04	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	12.11	Sales Y/Y TTM	-	Profit Margin	-63.35%	RSI (14)	77.46	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	12.50	EPS Q/Q	-25.79%	SMA20	22.35%	Beta	1.23	Target Price	27.00
Payout	-	Debt/Eq	0.13	Sales Q/Q	31.37%	SMA50	47.04%	Rel Volume	0.86	Prev Close	20.41
Employees	281	LT Debt/Eq	0.12	Earnings	Nov 04 AMC	SMA200	34.01%	Avg Volume	384.24K	Price	20.93
IPO	Oct 11, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	10.67% 3.76%	Trades		Volume	330,861	Change	2.55%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-21-25	Initiated	Raymond James	Strong Buy	$19
Jun-24-25	Initiated	BTIG Research	Buy	$30
Apr-04-25	Initiated	Ladenburg Thalmann	Buy	$32
Nov-05-24	Initiated	William Blair	Outperform
Nov-05-24	Initiated	TD Cowen	Buy	$31
Nov-05-24	Initiated	JP Morgan	Overweight	$32
Nov-05-24	Initiated	Canaccord Genuity	Buy	$30
Nov-05-24	Initiated	BofA Securities	Buy	$32

Dec-12-25 10:02AM	CBLL Gets FDA Consent for One-of-a-Kind Delirium Monitoring Solution (Zacks)
09:49AM	AI Diagnostics Hit Critical Mass as Hospitals Race to Cut Costs (PR Newswire)
Dec-09-25 08:00AM	Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution (GlobeNewswire)
Nov-24-25 08:00AM	Ceribell Receives FDA 510(k) Clearance for Use of Clarity? Algorithm for Neonates (GlobeNewswire)
Nov-19-25 04:05PM	Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
04:05PM	Loading…
Nov-06-25 04:05PM	Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire)
Nov-05-25 12:06AM	CeriBell Inc (CBLL) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com) +7.88%
Nov-04-25 06:05PM	CeriBell, Inc. (CBLL) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
04:05PM	Ceribell Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Oct-29-25 10:00AM	Will Evolus, Inc. (EOLS) Report Negative Earnings Next Week? What You Should Know (Zacks) -6.24%
Oct-28-25 10:00AM	CeriBell, Inc. (CBLL) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Oct-21-25 04:05PM	Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025 (GlobeNewswire) +7.04%
Sep-22-25 08:00AM	Medtech Leader Erica Rogers Joins Ceribell Board of Directors (GlobeNewswire)
Aug-13-25 12:08PM	J.P. Morgan Maintains a Buy Rating on CeriBell (CBLL) With a $21 PT (Insider Monkey)
Aug-05-25 04:05PM	Ceribell Reports Second Quarter 2025 Financial Results (GlobeNewswire) -15.25%
04:05PM	Loading…
Jul-29-25 04:05PM	Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference (GlobeNewswire)
03:20PM	Medtech IPOs Spur Talk of Broader US Health-Care Listing Revival (Bloomberg)
Jul-22-25 04:05PM	Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025 (GlobeNewswire)
Jul-07-25 04:42PM	Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware (GlobeNewswire) -9.14%
Jun-20-25 09:11AM	AI Tools That Talk, Scan, and Save Lives Are Reshaping the Investment Landscape (PR Newswire)
May-29-25 05:44AM	The medtech IPO window is finally open. Or is it? (MedTech Dive)
May-20-25 04:05PM	Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference (GlobeNewswire)
May-09-25 03:43AM	CeriBell Inc (CBLL) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Growth Amid ... (GuruFocus.com) -6.61%
May-08-25 04:05PM	Ceribell Reports First Quarter 2025 Financial Results (GlobeNewswire) +6.81%
Apr-30-25 04:05PM	Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference (GlobeNewswire)
08:00AM	Ceribell Receives FedRAMP High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems (GlobeNewswire)
Apr-24-25 04:05PM	Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025 (GlobeNewswire)
Apr-23-25 02:58PM	TimesSquare U.S. Small Cap Growth Strategy Q1 2025 Commentary (Seeking Alpha)
Apr-21-25 05:00AM	Ceribell wins FDA nod for algorithm to detect pediatric seizures (MedTech Dive)
Apr-16-25 10:40AM	CBLL Stock Falls Despite FDA Clearance for Pediatric Clarity Algorithm (Zacks)
08:00AM	Loading…
Apr-15-25 08:00AM	FDA Clears Ceribell's Clarity Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older (GlobeNewswire)
Apr-07-25 01:04PM	CeriBell's IPO Lockup Ends April 9 - Here's Why We're Shorting It Today (Seeking Alpha)
Apr-05-25 11:00AM	Markets Watch Out For Core CPI With Big Banks Set To Report Earnings (Seeking Alpha)
Feb-26-25 02:15AM	CeriBell Inc (CBLL) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic Growth Amid ... (GuruFocus.com)
Feb-25-25 04:05PM	Ceribell Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-18-25 04:05PM	Ceribell to Participate in the 45th Annual TD Cowen Healthcare Conference (GlobeNewswire)
Feb-11-25 04:05PM	Ceribell to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025 (GlobeNewswire)
Dec-23-24 04:05PM	Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-19-24 08:00AM	Ceribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing (GlobeNewswire)
07:01AM	Meet the biophysicist whose seizure-detection company is using AI to get a better read on peoples brains (FastCompany)
Nov-13-24 11:55PM	Ceribell, Inc. Reports Strong Q3 2024 Growth (TipRanks)
Nov-12-24 04:05PM	Ceribell Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-11-24 08:00AM	Ceribell Receives Authority to Operate from the U.S. Department of Veterans Affairs (GlobeNewswire)
Nov-07-24 04:05PM	Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire)
Nov-06-24 06:31AM	Ceribell initiated with a Buy at BofA on differentiated AI algorithm (TipRanks)
Oct-29-24 04:05PM	Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024 (PR Newswire)
Oct-18-24 01:01AM	TPG GP A, LLC Acquires New Stake in CeriBell Inc (GuruFocus.com)
Oct-16-24 04:05PM	New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG (PR Newswire)
Oct-15-24 05:00PM	CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares (PR Newswire)
Oct-14-24 06:45AM	Opening Day: Another trio of biotech IPOs make Friday debut (TipRanks)
Oct-11-24 05:00PM	CeriBell Shares Rise 47% to Lead Trio of Life Sciences IPOs (Bloomberg)
10:15AM	CeriBell IPO: Stock price soars as AI brain-monitoring headband maker debuts on Nasdaq (FastCompany)
08:45AM	Upstream Bio Leads Life Sciences IPOs With Upsized Listing (Bloomberg)
Oct-10-24 11:27PM	CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering (PR Newswire)

Ceribell, Inc. is a commercial-stage medical technology company, which engages in the provision of transforming the diagnosis and management of patients with serious neurological conditions. Its products include Point-of-Care EEG, which enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies, Clarity, an AI algorithm that interprets EEG in real-time, providing bedside alerts and continuous monitoring for status epilepticus, and EEG Portal, which makes it easy to remotely review EEG in real-time with pre-annotated EEG insights. The company was founded by Xing Juan Chao, Josef Parvizi, and Chris Chafe on August 29, 2014 and is headquartered in Sunnyvale, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BURKE WILLIAM W	Director	Dec 09 '25	Option Exercise	3.97	32,728	130,085	40,391	Dec 11 04:48 PM
BURKE WILLIAM W	Director	Dec 09 '25	Sale	22.02	32,728	720,671	17,391	Dec 11 04:48 PM
Parvizi Josef	Director	Dec 08 '25	Sale	20.26	25,000	506,500	797,652	Dec 10 08:00 PM
ROBERTSON REBECCA B	Director	Dec 08 '25	Option Exercise	2.24	5,000	11,200	13,388	Dec 10 01:02 PM
ROBERTSON REBECCA B	Director	Dec 08 '25	Sale	20.00	5,000	100,000	8,388	Dec 10 01:02 PM
BURKE WILLIAM W	Director	Dec 09 '25	Proposed Sale	22.02	32,728	720,688		Dec 09 04:05 PM
Parvizi Josef	Director	Dec 08 '25	Proposed Sale	20.26	25,000	506,467		Dec 08 04:28 PM
Chao Xingjuan	President and CEO	Dec 04 '25	Option Exercise	2.24	25,000	56,000	823,135	Dec 08 01:01 PM
Chao Xingjuan	President and CEO	Dec 04 '25	Sale	18.82	25,000	470,500	798,135	Dec 08 01:01 PM
ROBERTSON REBECCA B	Director	Dec 08 '25	Proposed Sale	20.00	5,000	100,000		Dec 08 12:27 PM
Foehr David	Senior VP, Finance and PAO	Dec 03 '25	Option Exercise	4.70	4,399	20,675	21,630	Dec 05 05:35 PM
Foehr David	Senior VP, Finance and PAO	Dec 03 '25	Sale	16.83	5,265	88,610	19,384	Dec 05 05:35 PM
Chao Xingjuan	Officer	Dec 04 '25	Proposed Sale	18.82	25,000	470,534		Dec 04 04:44 PM
ROBERTSON REBECCA B	Director	Dec 02 '25	Sale	16.67	827	13,786	8,388	Dec 04 02:16 PM
Woo Raymond	Chief Technology Officer	Dec 01 '25	Option Exercise	4.37	11,112	48,605	178,816	Dec 03 01:34 PM
Woo Raymond	Chief Technology Officer	Dec 01 '25	Sale	12.28	11,112	136,455	167,704	Dec 03 01:34 PM
Chao Xingjuan	President and CEO	Dec 01 '25	Option Exercise	3.65	25,000	91,250	823,135	Dec 03 01:33 PM
Chao Xingjuan	President and CEO	Dec 01 '25	Sale	16.59	25,000	414,750	798,135	Dec 03 01:33 PM
Foehr David	Officer	Dec 03 '25	Proposed Sale	16.83	5,265	88,610		Dec 03 10:06 AM
ROBERTSON REBECCA B	Director	Dec 02 '25	Proposed Sale	16.67	827	13,786		Dec 02 09:50 AM
Chao Xingjuan	Officer	Dec 01 '25	Proposed Sale	16.87	25,000	421,750		Dec 01 12:20 PM
Woo Raymond	Officer	Dec 01 '25	Proposed Sale	16.87	11,112	187,459		Dec 01 10:17 AM
Chao Xingjuan	President and CEO	Nov 21 '25	Option Exercise	2.94	50,000	147,250	848,135	Nov 25 06:39 PM
Chao Xingjuan	President and CEO	Nov 21 '25	Sale	15.13	50,000	756,500	798,135	Nov 25 06:39 PM
Chao Xingjuan	Officer	Nov 21 '25	Proposed Sale	15.13	50,000	756,539		Nov 21 04:52 PM
Woo Raymond	Chief Technology Officer	Nov 11 '25	Option Exercise	4.37	11,112	48,605	178,816	Nov 13 01:50 PM
Woo Raymond	Chief Technology Officer	Nov 11 '25	Sale	12.28	11,112	136,455	167,704	Nov 13 01:50 PM
Woo Raymond	Officer	Nov 11 '25	Proposed Sale	12.28	11,112	136,497		Nov 12 07:12 AM
Woo Raymond	Chief Technology Officer	Oct 03 '25	Option Exercise	4.37	11,112	48,605	178,816	Oct 07 06:29 PM
Woo Raymond	Chief Technology Officer	Oct 03 '25	Sale	12.54	11,112	139,344	167,704	Oct 07 06:29 PM
Woo Raymond	Officer	Oct 03 '25	Proposed Sale	12.54	11,112	139,315		Oct 03 04:40 PM
Woo Raymond	Chief Technology Officer	Sep 04 '25	Option Exercise	4.37	11,112	48,605	178,816	Sep 08 01:28 PM
Woo Raymond	Chief Technology Officer	Sep 04 '25	Sale	12.11	11,112	134,566	167,704	Sep 08 01:28 PM
ROBERTSON REBECCA B	Director	Sep 03 '25	Sale	11.36	827	9,395	9,215	Sep 05 02:33 PM
Woo Raymond	Officer	Sep 04 '25	Proposed Sale	12.11	11,112	134,610		Sep 04 04:13 PM
Woo Raymond	Chief Technology Officer	Sep 02 '25	Option Exercise	2.24	20,000	44,800	167,704	Sep 04 12:58 PM
ROBERTSON REBECCA B	Director	Sep 03 '25	Proposed Sale	11.36	827	9,395		Sep 03 10:34 AM
Foehr David	Senior VP, Finance and PAO	Aug 27 '25	Sale	11.71	866	10,141	20,250	Aug 29 12:06 PM
Foehr David	Officer	Aug 27 '25	Proposed Sale	11.71	866	10,143		Aug 27 04:50 PM
Taylor Joseph Michael	Director	Aug 19 '25	Sale	11.76	7,032	82,696	59,235	Aug 21 02:47 PM
Taylor Joseph Michael	Director	Aug 19 '25	Proposed Sale	11.76	7,032	82,690		Aug 19 05:12 PM
Chao Xingjuan	President and CEO	Jul 07 '25	Option Exercise	2.24	25,000	56,000	801,222	Jul 09 02:49 PM
Chao Xingjuan	President and CEO	Jul 07 '25	Sale	17.70	25,000	442,500	776,022	Jul 09 02:49 PM
Chao Xingjuan	Officer	Jul 07 '25	Proposed Sale	18.80	25,000	470,000		Jul 07 01:07 PM
ROBERTSON REBECCA B	Director	Jun 18 '25	Sale	17.85	11,188	199,706	10,042	Jun 20 12:31 PM
ROBERTSON REBECCA B	Director	Jun 17 '25	Sale	17.63	7,445	131,255	21,230	Jun 20 12:31 PM
Copp Joshua	Former Officer	Jun 18 '25	Proposed Sale	17.85	11,188	199,715		Jun 18 01:23 PM
ROBERTSON REBECCA B	Director	Jun 16 '25	Option Exercise	3.61	20,000	72,232	48,675	Jun 17 07:52 PM
ROBERTSON REBECCA B	Director	Jun 16 '25	Sale	17.14	20,000	342,800	28,675	Jun 17 07:52 PM
ROBERTSON REBECCA B	Director	Jun 17 '25	Proposed Sale	17.09	7,445	127,235		Jun 17 10:19 AM
ROBERTSON REBECCA B	Director	Jun 16 '25	Proposed Sale	17.14	20,000	342,738		Jun 16 04:17 PM
Copp Joshua	Former Officer	Jun 13 '25	Proposed Sale	18.00	6,859	123,484		Jun 13 04:22 PM
Chao Xingjuan	President and CEO	Jun 03 '25	Option Exercise	2.24	25,000	56,000	801,022	Jun 05 06:34 PM
Chao Xingjuan	President and CEO	Jun 03 '25	Sale	17.00	25,000	425,000	776,022	Jun 05 06:34 PM
Chao Xingjuan	Officer	Jun 03 '25	Proposed Sale	17.15	25,000	428,750		Jun 03 10:06 AM
Chao Xingjuan	President and CEO	May 15 '25	Option Exercise	1.02	73,871	75,060	776,022	May 19 12:33 PM
Chao Xingjuan	President and CEO	May 15 '25	Sale	16.96	25,000	424,000	727,151	May 19 12:33 PM
Chao Xingjuan	Officer	May 15 '25	Proposed Sale	16.59	25,000	414,750		May 15 10:47 AM
Chao Xingjuan	President and CEO	Apr 23 '25	Sale	15.11	15,628	236,139	727,151	Apr 24 04:47 PM
Chao Xingjuan	President and CEO	Apr 22 '25	Sale	15.06	300	4,518	742,779	Apr 24 04:47 PM
Chao Xingjuan	Officer	Apr 23 '25	Proposed Sale	15.11	15,628	236,085		Apr 23 04:11 PM
Chao Xingjuan	Officer	Apr 22 '25	Proposed Sale	15.06	300	4,518		Apr 22 04:10 PM
Chao Xingjuan	President and CEO	Apr 17 '25	Sale	15.02	5,700	85,614	746,451	Apr 21 09:31 PM
Chao Xingjuan	President and CEO	Apr 21 '25	Sale	15.03	3,372	50,681	743,079	Apr 21 09:31 PM
Chao Xingjuan	Officer	Apr 21 '25	Proposed Sale	15.03	3,372	50,664		Apr 21 04:07 PM
Chao Xingjuan	Officer	Apr 17 '25	Proposed Sale	15.02	5,700	85,612		Apr 17 04:13 PM
Blumberg Scott	Chief Financial Officer	Dec 23 '24	Option Exercise	2.26	1,000	2,260	89,366	Dec 26 11:23 AM

ATGE Adtalem Global Education Inc daily Stock Chart

Peers: LOPE PRDO STRA CHGG LRN BEDU UTI AFYA GHC STG

| Held by: IJR VTI IWM VB VBR VXF SPSM IWO IJT DFAT

Index	RUT	P/E	13.94	EPS (ttm)	6.66	Insider Own	2.68%	Shs Outstand	36.32M	Perf Week	-1.76%
Market Cap	3.37B	Forward P/E	10.76	EPS next Y	8.63	Insider Trans	-5.46%	Shs Float	35.36M	Perf Month	-4.11%
Enterprise Value	3.87B	PEG	-	EPS next Q	2.17	Inst Own	97.35%	Short Float	2.89%	Perf Quarter	-31.41%
Income	252.17M	P/S	1.84	EPS this Y	13.08%	Inst Trans	0.13%	Short Ratio	1.83	Perf Half Y	-23.77%
Sales	1.83B	P/B	2.31	EPS next Y	14.48%	ROA	8.71%	Short Interest	1.02M	Perf YTD	2.23%
Book/sh	40.13	P/C	12.06	EPS next 5Y	-	ROE	17.38%	52W High	156.26 -40.56%	Perf Year	5.22%
Cash/sh	7.70	P/FCF	10.44	EPS past 3/5Y	- 10.18%	ROIC	11.47%	52W Low	84.79 9.54%	Perf 3Y	138.46%
Dividend Est.	-	EV/EBITDA	8.71	Sales past 3/5Y	8.97% 11.19%	Gross Margin	60.01%	Volatility	2.04% 3.14%	Perf 5Y	217.86%
Dividend TTM	-	EV/Sales	2.11	EPS Y/Y TTM	52.97%	Oper. Margin	19.59%	ATR (14)	3.48	Perf 10Y	302.60%
Dividend Ex-Date	Nov 30, 2016	Quick Ratio	0.98	Sales Y/Y TTM	12.24%	Profit Margin	13.76%	RSI (14)	33.12	Recom	1.25
Dividend Gr. 3/5Y	- -	Current Ratio	0.98	EPS Q/Q	39.60%	SMA20	-0.81%	Beta	0.69	Target Price	158.25
Payout	0.00%	Debt/Eq	0.53	Sales Q/Q	10.75%	SMA50	-19.98%	Rel Volume	0.86	Prev Close	93.10
Employees	10371	LT Debt/Eq	0.51	Earnings	Oct 30 AMC	SMA200	-21.91%	Avg Volume	558.43K	Price	92.88
IPO	Jun 21, 1991	Option/Short	Yes / Yes	EPS/Sales Surpr.	10.94% 2.21%	Trades		Volume	478,178	Change	-0.24%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-23-25	Initiated	Jefferies	Buy	$135
Oct-27-23	Upgrade	Robert W. Baird	Neutral → Outperform	$47 → $55
Jul-07-23	Upgrade	BMO Capital Markets	Market Perform → Outperform	$44
Aug-23-21	Resumed	BMO Capital Markets	Market Perform	$40
Sep-12-19	Initiated	Sidoti	Buy

Dec-11-25 09:45AM	Here's Why Adtalem Global Education (ATGE) is a Strong Growth Stock (Zacks)
Dec-09-25 09:40AM	Adtalem Global Education (ATGE) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
Dec-05-25 11:40AM	ATGE or LINC: Which Is the Better Value Stock Right Now? (Zacks)
09:40AM	Is Intercontinental Hotels Group (IHG) Stock Outpacing Its Consumer Discretionary Peers This Year? (Zacks)
Dec-04-25 09:54AM	Stride is Trading at a Discount: Right Time to Buy the Stock? (Zacks)
09:55AM	Loading…
Dec-03-25 09:55AM	Wall Street Analysts Predict a 76.62% Upside in Adtalem (ATGE): Here's What You Should Know (Zacks)
09:51AM	Zacks Industry Outlook Highlights Grand Canyon Education, McGraw Hill, Adtalem Global Education, Perdoceo Education and Nerdy (Zacks)
Dec-02-25 11:39PM	3 Russell 2000 Stocks Walking a Fine Line (StockStory)
Dec-01-25 11:30AM	5 School Stocks Leveraging AI, Digital Learning & Healthcare Shortages (Zacks)
Nov-30-25 10:37PM	Spotting Winners: Adtalem (NYSE:ATGE) And Education Services Stocks In Q3 (StockStory)
Nov-28-25 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Adtalem (ATGE) (Zacks)
Nov-25-25 09:45AM	Why Adtalem Global Education (ATGE) is a Top Growth Stock for the Long-Term (Zacks)
Nov-20-25 09:40AM	Here's Why Adtalem Global Education (ATGE) is a Strong Value Stock (Zacks)
Nov-19-25 11:40AM	ATGE vs. LINC: Which Stock Is the Better Value Option? (Zacks)
09:41AM	Is ADTALEM GBL EDU (ATGE) Outperforming Other Consumer Discretionary Stocks This Year? (Zacks)
09:35AM	Loading…
09:35AM	After Plunging 37.5% in 4 Weeks, Here's Why the Trend Might Reverse for Adtalem (ATGE) (Zacks)
Nov-18-25 11:35PM	1 Small-Cap Stock to Keep an Eye On and 2 We Brush Off (StockStory)
Nov-12-25 12:45PM	Is Adtalem (ATGE) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
Nov-11-25 01:22PM	American Public Q3 Earnings & Revenues Top Estimates, Both Rise Y/Y (Zacks)
Nov-06-25 12:36AM	The 5 Most Interesting Analyst Questions From Adtalem's Q3 Earnings Call (StockStory)
Nov-05-25 06:00AM	Adtalem Accelerates $150 Million Share Repurchase Program (Business Wire) +5.71%
Nov-04-25 09:45AM	Here's Why Adtalem Global Education (ATGE) is a Strong Growth Stock (Zacks)
Nov-03-25 11:40AM	ATGE vs. LOPE: Which Stock Should Value Investors Buy Now? (Zacks)
Oct-31-25 01:01PM	Why Adtalem (ATGE) Shares Are Falling Today (StockStory) -30.86%
08:50AM	ATGE Q3 Deep Dive: Enrollment Growth and Operational Challenges Shape Outlook (StockStory)
Oct-30-25 11:04PM	Adtalem Global Education Inc (ATGE) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
06:10PM	Adtalem Global Education (ATGE) Tops Q1 Earnings and Revenue Estimates (Zacks)
05:37PM	Adtalem's (NYSE:ATGE) Q3: Beats On Revenue (StockStory)
05:10PM	Adtalem: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:15PM	Adtalem Global Education First Quarter Fiscal Year 2026 Results; Maintains Fiscal Year 2026 Guidance (Business Wire)
11:05PM	Loading…
Oct-28-25 11:05PM	Adtalem Earnings: What To Look For From ATGE (StockStory) -8.40%
Oct-27-25 10:17AM	Stride to Report Q1 Earnings: Time to Buy or Sell This School Stock? (Zacks)
08:34AM	1 Profitable Stock with Solid Fundamentals and 2 That Underwhelm (StockStory)
Oct-23-25 08:00AM	Adtalem Global Education Expands Pathways to Medical School (Business Wire)
Oct-17-25 03:29PM	Adtalem Global Education CEO: AI can improve the healthcare experience for patients and clinicians (CNBC TV)
Oct-13-25 09:40AM	Is Melco Resorts & Entertainment Limited (MLCO) Outperforming Other Consumer Discretionary Stocks This Year? (Zacks)
12:03AM	Adtalem (ATGE): Buy, Sell, or Hold Post Q2 Earnings? (StockStory)
Oct-10-25 11:40AM	ATGE or LINC: Which Is the Better Value Stock Right Now? (Zacks)
Oct-09-25 04:02PM	Implied Volatility Surging for Adtalem Global Education Stock Options (Zacks)
Oct-07-25 02:40PM	Adtalem, Perdoceo Education, Universal Technical Institute, Pursuit Attractions and Hospitality, and Sphere Entertainment Shares Are Falling, What You Need To Know (StockStory)
Oct-06-25 01:06PM	Can these educational stocks keep going higher? (Investing.com)
Oct-04-25 12:31AM	1 Mooning Stock to Consider Right Now and 2 That Underwhelm (StockStory)
Oct-03-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Oct-02-25 08:30AM	Adtalem Global Education Announces First Quarter 2026 Conference Call (Business Wire)
Sep-25-25 09:40AM	Are Consumer Discretionary Stocks Lagging ADTALEM GBL EDU (ATGE) This Year? (Zacks)
Sep-24-25 10:02AM	Is Career Learning Shaping the Path for Stride's Growth? (Zacks)
01:00AM	Buy This Stock on the Dip. Shares Can Rise Nearly 40%. (Barrons.com)
Sep-10-25 12:00PM	Adtalem (ATGE) Upgraded to Buy: Here's What You Should Know (Zacks)
05:14AM	Adtalem Global Education Inc. (ATGE) Attracts Landscape Capital's Backing (Insider Monkey)
Sep-08-25 04:59PM	Is ADTALEM GBL EDU (ATGE) Stock Outpacing Its Consumer Discretionary Peers This Year? (Zacks)
04:29PM	If You Invested $1000 in Adtalem Global Education a Decade Ago, This is How Much It'd Be Worth Now (Zacks)
08:30AM	Adtalem Global Education to Participate in September Investor Conferences (Business Wire)
Sep-04-25 11:36PM	Q2 Earnings Outperformers: Adtalem (NYSE:ATGE) And The Rest Of The Education Services Stocks (StockStory)
Sep-03-25 09:59AM	Is Stride's Investment in Tutoring the Key to Growth Retention? (Zacks)
Sep-02-25 11:44AM	LRN Stock Surges 15% in 3 Months: Should Investors Buy it Now? (Zacks)
Sep-01-25 09:50AM	Here's Why Adtalem Global Education (ATGE) is a Strong Momentum Stock (Zacks)
Aug-28-25 09:21AM	Do Options Traders Know Something About ATGE Stock We Don't? (Zacks)
Aug-26-25 09:40AM	Here's Why Adtalem Global Education (ATGE) is a Strong Value Stock (Zacks)
Aug-21-25 08:30AM	If You Invested $1000 in Adtalem Global Education a Decade Ago, This is How Much It'd Be Worth Now (Zacks)
Aug-18-25 01:40PM	This Online Education Stock Flirts With A Buy Point; Here's Why Its CEO Reports 'A Defining Moment' (Investor's Business Daily)
09:40AM	Is Amer Sports, Inc. (AS) Outperforming Other Consumer Discretionary Stocks This Year? (Zacks)
08:50AM	Here's Why Momentum in Adtalem (ATGE) Should Keep going (Zacks)
Aug-14-25 01:32AM	5 Insightful Analyst Questions From Adtalem's Q2 Earnings Call (StockStory)
Aug-12-25 03:21AM	ATGE Q2 Deep Dive: Health Care Enrollment and Partnerships Drive Outperformance (StockStory) +5.63%
Aug-08-25 09:40AM	Why Adtalem Global Education (ATGE) is a Top Value Stock for the Long-Term (Zacks)
05:14AM	Adtalem (NYSE:ATGE) Beats Expectations in Strong Q2, Full-Year Sales Guidance is Optimistic (StockStory)
03:38AM	Adtalem Global Education Inc (ATGE) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Aug-07-25 07:25PM	Adtalem Global Education (ATGE) Tops Q4 Earnings and Revenue Estimates (Zacks)
06:25PM	Adtalem: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:15PM	Adtalem Global Education Announces Exceptional Fiscal Year 2025 Results; Initiates Fiscal Year 2026 Guidance (Business Wire)
Aug-06-25 05:45PM	Universal Technical Institute (UTI) Q3 Earnings and Revenues Beat Estimates (Zacks)
12:32PM	Disney Q3 Earnings Surpass Estimates, Revenues Increase Y/Y (Zacks)
07:00AM	Adtalem Global Education and Sallie Mae Sign Letter of Intent to Explore New Student Financing Model (Business Wire)
Aug-05-25 11:06PM	Earnings To Watch: Adtalem (ATGE) Reports Q2 Results Tomorrow (StockStory)
08:12AM	Grab These 4 Stocks With Solid Net Profit Margin to Enhance Returns (Zacks)
Aug-01-25 11:40AM	ATGE vs. UTI: Which Stock Is the Better Value Option? (Zacks)
09:40AM	Has Boyd Gaming (BYD) Outpaced Other Consumer Discretionary Stocks This Year? (Zacks)
09:35AM	Down 7.1% in 4 Weeks, Here's Why Adtalem (ATGE) Looks Ripe for a Turnaround (Zacks)
Jul-31-25 10:00AM	Adtalem Global Education (ATGE) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jul-24-25 11:31PM	Education Services Stocks Q1 Results: Benchmarking Adtalem (NYSE:ATGE) (StockStory)
Jul-22-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Jul-21-25 11:49AM	Stride Stock Tumbles 9% in Past Month: Should You Buy the Dip or Wait? (Zacks)
07:56AM	Adtalem Global Education (ATGE) Surged on Student Enrollment Growth and Raise in Guidance (Insider Monkey)
Jul-16-25 09:40AM	Is ADTALEM GBL EDU (ATGE) Stock Outpacing Its Consumer Discretionary Peers This Year? (Zacks)
Jul-09-25 05:00AM	Chamberlain University and SSM Health Launch Landmark Partnership to Address Nursing Shortage (Business Wire)
Jul-08-25 01:06PM	Motley Fool Investors Look Back at the First Half of 2025 (Motley Fool)
09:50AM	Why Adtalem Global Education (ATGE) is a Top Momentum Stock for the Long-Term (Zacks)
Jul-07-25 08:00AM	Adtalem Global Education Announces Fourth Quarter and Fiscal Year 2025 Conference Call (Business Wire)
Jul-04-25 01:32AM	The 5 Most Interesting Analyst Questions From Adtalem's Q1 Earnings Call (StockStory)
Jul-03-25 09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
08:45AM	Buy These 4 Stocks With Solid Net Profit Margins to Enhance Returns (Zacks)
Jun-30-25 09:40AM	Are Consumer Discretionary Stocks Lagging ADTALEM GBL EDU (ATGE) This Year? (Zacks)
Jun-26-25 10:25AM	Is Stride's Expanding EBITDA Margin a Sign of Operating Leverage? (Zacks)
Jun-24-25 12:03AM	Adtalem (ATGE): Buy, Sell, or Hold Post Q1 Earnings? (StockStory)
Jun-19-25 09:42AM	Stride's Earnings Estimates Trending Up: Is It Time to Buy the Stock? (Zacks)
Jun-18-25 08:31AM	Is Stride Making a Long-Term Bet on Career-Driven High Schools? (Zacks)
12:35AM	1 Profitable Stock with Exciting Potential and 2 to Avoid (StockStory)
Jun-17-25 09:40AM	Here's Why Adtalem Global Education (ATGE) is a Strong Value Stock (Zacks)
Jun-13-25 11:40AM	ATGE or UTI: Which Is the Better Value Stock Right Now? (Zacks)
10:55AM	Can Stride Stay Ahead in a Crowded Digital Education Field? (Zacks)

Adtalem Global Education, Inc. engages in the provision of post-secondary education. It operates through the following segments: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment offers degree and non-degree programs in the nursing and health professions postsecondary education industry. The Walden segment covers online certificates, bachelor's, master's, and doctoral degrees, including those in nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. The Medical and Veterinary segment includes degree and non-degree programs in the medical and veterinary postsecondary education industry. The company was founded by Dennis J. Keller and Ronald L. Taylor in 1973 and is headquartered in Chicago, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Phelan Kenneth J	Director	Nov 05 '25	Buy	98.29	508	49,931	18,783	Nov 05 04:12 PM
MALAFRONTE MICHAEL W	Lead Independent Director	Nov 04 '25	Buy	91.85	1,000	91,850	100,445	Nov 04 04:43 PM
WARDELL LISA W	Director	Aug 28 '25	Sale	132.38	25,477	3,372,663	43,451	Aug 29 04:20 PM
LISA W. WARDELL	Director	Aug 28 '25	Proposed Sale	132.38	25,477	3,372,663		Aug 28 04:15 PM
WARDELL LISA W	Director	Aug 27 '25	Sale	135.22	18,392	2,486,889	68,928	Aug 27 05:47 PM
Gangadharan Manjunath	VP, Chief Accounting Officer	Aug 27 '25	Sale	135.67	944	128,072	4,901	Aug 27 05:39 PM
MANJUNATH GANGADHARAN	Officer	Aug 27 '25	Proposed Sale	135.90	944	128,290		Aug 27 04:25 PM
LISA W. WARDELL	Director	Aug 27 '25	Proposed Sale	135.22	18,392	2,486,889		Aug 27 04:11 PM
WARDELL LISA W	Director	Aug 21 '25	Sale	132.90	12,900	1,714,465	92,477	Aug 25 04:11 PM
Lisa W. Wardell	Director	Aug 21 '25	Proposed Sale	132.89	12,900	1,714,281		Aug 21 04:36 PM
BURKE WILLIAM W	Director	Jun 05 '25	Sale	128.35	2,291	294,048	9,368	Jun 06 04:32 PM
BURKE WILLIAM W	Director	Jun 05 '25	Proposed Sale	128.13	2,291	293,548		Jun 05 04:40 PM
Gangadharan Manjunath	VP, Chief Accounting Officer	May 21 '25	Sale	131.66	966	127,184	4,300	May 22 04:20 PM
MANJUNATH GANGADHARAN	Officer	May 21 '25	Proposed Sale	133.28	966	128,748		May 21 04:19 PM
BLAKE CORBETT SIMPSON	Terminated officer within 90da	May 15 '25	Proposed Sale	130.25	620	80,756		May 15 04:33 PM
MALAFRONTE MICHAEL W	Lead Independent Director	Mar 07 '25	Buy	87.21	1,000	87,210	99,445	Mar 07 04:18 PM
Hrinak Donna J	Director	Feb 21 '25	Sale	97.92	915	89,597	7,117	Feb 24 04:15 PM
Hrinak Donna J	Director	Feb 21 '25	Proposed Sale	105.09	915	96,161		Feb 21 10:22 AM
Hrinak Donna J	Director	Feb 14 '25	Sale	103.26	4,812	496,872	8,032	Feb 18 04:27 PM
DONNA JEAN HRINAK	Director	Feb 14 '25	Proposed Sale	103.26	4,812	496,872		Feb 14 04:07 PM
Hrinak Donna J	Director	Feb 06 '25	Sale	108.68	4,685	509,162	12,844	Feb 10 04:24 PM
Betz Michael	Pres. Walden University & CDO	Feb 06 '25	Sale	108.57	3,500	379,993	16,881	Feb 07 04:23 PM
DONNA JEAN HRINAK	Director	Feb 06 '25	Proposed Sale	108.68	4,685	509,162		Feb 06 04:21 PM
MICHAEL BETZ	Officer	Feb 06 '25	Proposed Sale	108.57	3,500	379,993		Feb 06 04:17 PM
MAYUR GUPTA	Former Director	Dec 23 '24	Proposed Sale	88.42	1,100	97,262		Dec 23 04:12 PM

Open in Screener

TCMD

Tactile Systems Technology Inc

Dec 12 • 04:00PM ET

27.82

-0.41 -1.45 %

Healthcare • Medical Devices • USA • NASD

TCMD Tactile Systems Technology Inc daily Stock Chart

Peers: ABT BSX BDX IART ZBH MLAB EW ISRG GMED SNN

| Held by: IWM VTI IWN AVUV DFAT VXF BSVO FESM DFAS NANC

Index	RUT	P/E	35.92	EPS (ttm)	0.77	Insider Own	3.81%	Shs Outstand	22.34M	Perf Week	-0.32%
Market Cap	621.38M	Forward P/E	27.27	EPS next Y	1.02	Insider Trans	-0.90%	Shs Float	21.44M	Perf Month	13.14%
Enterprise Value	572.14M	PEG	1.21	EPS next Q	0.44	Inst Own	92.99%	Short Float	8.66%	Perf Quarter	105.77%
Income	18.17M	P/S	1.99	EPS this Y	13.57%	Inst Trans	-2.01%	Short Ratio	4.85	Perf Half Y	182.72%
Sales	311.51M	P/B	3.03	EPS next Y	28.30%	ROA	6.64%	Short Interest	1.86M	Perf YTD	62.41%
Book/sh	9.18	P/C	9.42	EPS next 5Y	22.60%	ROE	8.80%	52W High	29.49 -5.66%	Perf Year	48.77%
Cash/sh	2.95	P/FCF	15.72	EPS past 3/5Y	- 4.69%	ROIC	8.31%	52W Low	8.61 223.12%	Perf 3Y	169.05%
Dividend Est.	-	EV/EBITDA	19.23	Sales past 3/5Y	12.09% 9.11%	Gross Margin	74.16%	Volatility	3.18% 4.10%	Perf 5Y	-33.70%
Dividend TTM	-	EV/Sales	1.84	EPS Y/Y TTM	21.00%	Oper. Margin	7.39%	ATR (14)	1.05	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.20	Sales Y/Y TTM	9.28%	Profit Margin	5.83%	RSI (14)	69.67	Recom	1.80
Dividend Gr. 3/5Y	- -	Current Ratio	3.61	EPS Q/Q	71.58%	SMA20	6.87%	Beta	0.92	Target Price	24.00
Payout	0.00%	Debt/Eq	0.08	Sales Q/Q	17.32%	SMA50	33.47%	Rel Volume	0.76	Prev Close	28.23
Employees	1037	LT Debt/Eq	0.07	Earnings	Nov 03 AMC	SMA200	95.34%	Avg Volume	383.09K	Price	27.82
IPO	Jul 28, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	114.41% 8.14%	Trades		Volume	292,497	Change	-1.45%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-04-25	Upgrade	BTIG Research	Neutral → Buy	$28
Oct-03-25	Initiated	Lake Street	Buy	$23.50
May-06-25	Downgrade	Piper Sandler	Overweight → Neutral	$14
Feb-19-25	Downgrade	B. Riley Securities	Buy → Neutral	$23 → $18
Nov-05-24	Downgrade	Oppenheimer	Outperform → Perform
Nov-05-24	Downgrade	BTIG Research	Buy → Neutral
Sep-26-24	Initiated	B. Riley Securities	Buy	$23
Nov-13-20	Upgrade	Oppenheimer	Perform → Outperform	$55
Oct-22-19	Initiated	Oppenheimer	Perform
Aug-07-19	Upgrade	BTIG Research	Neutral → Buy	$62
Jun-13-19	Initiated	Dougherty & Company	Buy	$80
Jan-02-19	Upgrade	Northland Capital	Under Perform → Market Perform
Jun-04-18	Downgrade	Northland Capital	Market Perform → Under Perform
Feb-27-18	Downgrade	Northland Capital	Outperform → Market Perform
Dec-08-17	Initiated	Sidoti	Neutral
Nov-09-17	Upgrade	BTIG Research	Neutral → Buy
Oct-12-17	Initiated	Guggenheim	Buy	$47

Show Previous Ratings

Nov-28-25 12:00PM	Tactile Systems Technology (TCMD) is a Great Momentum Stock: Should You Buy? (Zacks)
Nov-27-25 09:40AM	Are Medical Stocks Lagging Tactile Systems Technology (TCMD) This Year? (Zacks)
Nov-20-25 04:31AM	Zacks.com featured highlights include Tactile Systems, Canadian Natural Resources, Arlo and Celestica (Zacks)
Nov-19-25 10:00AM	Best Momentum Stock to Buy for Nov. 19th (Zacks)
09:27AM	4 Must-Buy Efficient Stocks to Strengthen Your Portfolio Returns (Zacks)
05:01AM	Loading…
05:01AM	New Strong Buy Stocks for Nov. 19: TCMD, NPSNY, and More (Zacks)
Nov-18-25 04:05PM	Tactile Medical to Present at the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
Nov-13-25 12:00PM	All You Need to Know About Tactile Systems Technology (TCMD) Rating Upgrade to Strong Buy (Zacks)
Nov-11-25 06:27AM	New Strong Buy Stocks for Nov. 11: HOOD, TCMD, and More (Zacks)
Nov-05-25 09:40AM	Is Tactile Systems Technology (TCMD) Stock Undervalued Right Now? (Zacks) +9.15%
Nov-04-25 12:04AM	Tactile Systems Technology Inc (TCMD) Q3 2025 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com) +40.65%
Nov-03-25 05:50PM	Tactile Systems Technology (TCMD) Beats Q3 Earnings and Revenue Estimates (Zacks)
04:48PM	Tactile Systems Technology: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Tactile Systems Technology, Inc. Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Oct-31-25 09:31AM	Earnings To Watch: Tactile Systems Technology Inc (TCMD) Reports Q3 2025 Result (GuruFocus.com)
05:40PM	Loading…
Oct-30-25 05:40PM	Alphatec (ATEC) Q3 Earnings and Revenues Surpass Estimates (Zacks)
Oct-29-25 05:55PM	Glaukos (GKOS) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
Oct-28-25 04:05PM	Landmark Study Demonstrates Sustained Clinical Benefits of Flexitouch Plus as First-Line Therapy in Treating Head and Neck Cancer-Related Lymphedema (GlobeNewswire)
Oct-20-25 04:05PM	Tactile Medical to Release Third Quarter of Fiscal Year 2025 Financial Results on November 3, 2025 (GlobeNewswire)
Sep-24-25 09:40AM	Is Tactile Systems Technology (TCMD) a Great Value Stock Right Now? (Zacks)
Sep-08-25 04:59PM	Should Value Investors Buy Tactile Systems Technology (TCMD) Stock? (Zacks)
04:34PM	LivaNova PLC (LIVN) Soars to 52-Week High, Time to Cash Out? (Zacks)
Aug-22-25 09:40AM	Are Investors Undervaluing Tactile Systems Technology (TCMD) Right Now? (Zacks)
Aug-06-25 09:40AM	Is Tactile Systems Technology (TCMD) Stock Undervalued Right Now? (Zacks)
09:35AM	Tactile Systems Technology (TCMD) Just Overtook the 20-Day Moving Average (Zacks)
09:30AM	Tactile Systems Technology (TCMD) Recently Broke Out Above the 50-Day Moving Average (Zacks)
Aug-05-25 03:05AM	Tactile Systems Technology Inc (TCMD) Q2 2025 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com) +26.79%
Aug-04-25 05:35PM	Tactile Systems Technology (TCMD) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
04:35PM	Tactile Systems Technology: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Tactile Systems Technology, Inc. Reports Second Quarter 2025 Financial Results (GlobeNewswire)
05:15PM	Loading…
Jul-30-25 05:15PM	DexCom (DXCM) Q2 Earnings and Revenues Top Estimates (Zacks)
Jul-21-25 04:05PM	Tactile Medical to Release Second Quarter of Fiscal Year 2025 Financial Results on August 4, 2025 (GlobeNewswire)
Jul-14-25 07:23AM	3 Small Caps Drawing Insider and Institutional Support (MarketBeat)
Jun-03-25 08:00AM	New Data Demonstrates Significant Clinical and Quality-of-Life Benefits of Flexitouch Plus in Treating Lymphedema Among Head and Neck Cancer Survivors (GlobeNewswire)
May-20-25 04:05PM	Tactile Medical to Present at Upcoming Investor Conferences in June (GlobeNewswire) -5.29%
May-06-25 12:09PM	Q1 2025 Tactile Systems Technology Inc Earnings Call (Thomson Reuters StreetEvents) -28.98%
03:08AM	Tactile Systems Technology Inc (TCMD) Q1 2025 Earnings Call Highlights: Navigating Growth and ... (GuruFocus.com)
May-05-25 05:30PM	Tactile Systems Technology (TCMD) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:27PM	Tactile Systems Technology: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Tactile Systems Technology, Inc. Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-02-25 09:33AM	What To Expect From Tactile Systems Technology Inc (TCMD) Q1 2025 Earnings (GuruFocus.com)
Apr-30-25 05:50PM	OPKO Health (OPK) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
Apr-21-25 04:05PM	Tactile Medical to Release First Quarter of Fiscal Year 2025 Financial Results on May 5, 2025 (GlobeNewswire)
Apr-07-25 12:58PM	Tactile Systems Technology: Interesting Devices Company, Need More Clarity (Seeking Alpha)
Mar-05-25 04:05PM	Tactile Medical to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference (GlobeNewswire)
Feb-19-25 11:23AM	Q4 2024 Tactile Systems Technology Inc Earnings Call (Thomson Reuters StreetEvents) -13.27%
02:06AM	Tactile Systems Technology Inc (TCMD) Q4 2024 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com)
Feb-18-25 07:20PM	Tactile Systems Technology (TCMD) Tops Q4 Earnings and Revenue Estimates (Zacks)
06:17PM	Tactile Systems Technology: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
02:52AM	Earnings To Watch: Tactile Systems Technology Inc (TCMD) Reports Q4 2024 Result (GuruFocus.com)
Feb-05-25 04:05PM	Tactile Medical to Release Fourth Quarter and Fiscal Year 2024 Financial Results on February 18, 2025 (GlobeNewswire)
Feb-04-25 08:00AM	Tactile Medical Expands Launch of Nimbl to Include Patients with Lower Extremity Lymphedema (GlobeNewswire)
Jan-13-25 08:00AM	Tactile Medical Appoints Laura King to Board of Directors (GlobeNewswire)
Jan-01-25 09:40AM	Is Tactile Systems Technology (TCMD) a Great Value Stock Right Now? (Zacks)
Dec-16-24 03:34PM	Should Value Investors Buy Tactile Systems Technology (TCMD) Stock? (Zacks)
Nov-28-24 09:40AM	Are Investors Undervaluing Tactile Systems Technology (TCMD) Right Now? (Zacks)
Nov-26-24 09:15AM	Tactile Systems Technology, Inc. (TCMD) Hit a 52 Week High, Can the Run Continue? (Zacks)
Nov-19-24 04:05PM	Tactile Medical to Present at the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire)
Nov-18-24 07:09AM	Bull Of The Day: Tactile Systems Technology (TCMD) (Zacks)
Nov-12-24 09:40AM	Is Tactile Systems Technology (TCMD) Stock Undervalued Right Now? (Zacks)
Nov-07-24 09:55AM	Wall Street Analysts Believe Tactile Systems Technology (TCMD) Could Rally 45.9%: Here's is How to Trade (Zacks)
Nov-04-24 05:30PM	Tactile Systems Technology (TCMD) Tops Q3 Earnings Estimates (Zacks) -11.12%
04:30PM	Tactile Systems Technology: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Tactile Systems Technology, Inc. Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-01-24 09:07AM	Earnings To Watch: Tactile Systems Technology Inc (TCMD) Reports Q3 2024 Result (GuruFocus.com)
Oct-28-24 10:01AM	Tactile Systems Technology (TCMD) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Oct-21-24 04:05PM	Tactile Medical to Release Third Quarter of Fiscal Year 2024 Financial Results on November 4, 2024 (GlobeNewswire)
Oct-04-24 06:05AM	These 2 Strong Buy Medical Device Stocks Are Poised for Growth, Says Analyst (TipRanks)
Oct-02-24 08:00AM	Tactile Medical Launches Next-Generation Nimbl Lymphedema Platform (GlobeNewswire)
Sep-25-24 12:02PM	UPDATE -- Tactile Medical Announces Positive Clinical Trial Results in Lymphedema Patients Using Advanced Pneumatic Compression Device Therapy (GlobeNewswire)
08:00AM	Tactile Medical Announces Positive Clinical Trial Results in Lymphedema Patients Using Advanced Pneumatic Compression Device Therapy (GlobeNewswire)
Sep-20-24 08:38AM	Implied Volatility Surging for Tactile Systems (TCMD) Stock Options (Zacks)
Sep-16-24 08:00AM	Tactile Medical Receives PDAC Approval for Nimbl Lymphedema Platform (GlobeNewswire)
Aug-07-24 09:55AM	Does Tactile Systems Technology (TCMD) Have the Potential to Rally 57.31% as Wall Street Analysts Expect? (Zacks)
09:40AM	Should Value Investors Buy Tactile Systems Technology (TCMD) Stock? (Zacks)
09:35AM	Tactile Systems Technology (TCMD) Recently Broke Out Above the 20-Day Moving Average (Zacks)
09:30AM	Tactile Systems Technology (TCMD) Crossed Above the 50-Day Moving Average: What That Means for Investors (Zacks)
Aug-06-24 01:59PM	Q2 2024 Tactile Systems Technology Inc Earnings Call (Thomson Reuters StreetEvents) +13.86%
Aug-05-24 06:15PM	Tactile Systems Technology (TCMD) Q2 Earnings and Revenues Surpass Estimates (Zacks) -5.87%
05:11PM	Tactile Systems Technology: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Tactile Systems Technology, Inc. Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-22-24 04:05PM	Tactile Medical to Release Second Quarter of Fiscal Year 2024 Financial Results on August 5, 2024 (GlobeNewswire)
Jun-27-24 02:03PM	The 3 Highest-Rated Medical Stocks You Can Buy Today (InvestorPlace)
May-21-24 04:05PM	Tactile Medical to Present at the William Blair 44th Annual Growth Stock Conference (GlobeNewswire) -5.93%
May-08-24 09:40AM	Are Investors Undervaluing Tactile Systems Technology (TCMD) Right Now? (Zacks)
May-07-24 10:48AM	Tactile Systems Technology, Inc. (NASDAQ:TCMD) Q1 2024 Earnings Call Transcript (Insider Monkey)
07:04AM	Q1 2024 Tactile Systems Technology Inc Earnings Call (Thomson Reuters StreetEvents)
03:13AM	Tactile Systems Technology Inc (TCMD) Q1 2024 Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com)
May-06-24 05:50PM	Tactile Systems Technology (TCMD) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:47PM	Tactile Systems Technology Inc (TCMD) Q1 2024 Earnings: Narrower Operating Loss and Revenue Growth (GuruFocus.com)
04:47PM	Tactile Systems Technology: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Tactile Systems Technology, Inc. Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-02-24 05:45PM	Tactile Systems Technology (TCMD) Rises But Trails Market: What Investors Should Know (Zacks)
09:00AM	Investors Heavily Search Tactile Systems Technology, Inc. (TCMD): Here is What You Need to Know (Zacks)
Apr-26-24 05:45PM	Tactile Systems Technology (TCMD) Increases Yet Falls Behind Market: What Investors Need to Know (Zacks)
Apr-24-24 07:09AM	Bull Of The Day: Tactile Systems Technology (TCMD) (Zacks)
Apr-23-24 04:05PM	Tactile Medical Announces CEO Transition and Preliminary First Quarter 2024 Revenue (GlobeNewswire)
09:30AM	Wall Street Analysts See Tactile Systems Technology (TCMD) as a Buy: Should You Invest? (Zacks)
Apr-18-24 05:45PM	Tactile Systems Technology (TCMD) Stock Moves -0.14%: What You Should Know (Zacks)

Tactile Systems Technology, Inc. engages in developing and providing medical devices for the treatment of underserved chronic diseases. It provides lymphedema solutions and offers Flexitouch Plus and Entre Plus systems products. The company was founded on January 30, 1995 and is headquartered in Minneapolis, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dodd Sheri Louise	Chief Executive Officer	Aug 08 '25	Sale	12.36	7,762	95,907	173,479	Aug 12 06:03 PM
Dodd Sheri Louise	Officer	Aug 08 '25	Proposed Sale	12.36	7,762	95,906		Aug 08 03:40 PM
Birkemeyer Elaine M.	Chief Financial Officer	May 12 '25	Sale	9.94	2,921	29,037	99,111	May 14 05:26 PM
Birkemeyer Elaine M.	Officer	May 12 '25	Proposed Sale	9.94	2,921	29,037		May 12 05:25 PM
Dodd Sheri Louise	Chief Executive Officer	May 08 '25	Sale	9.83	3,149	30,955	181,241	May 12 04:34 PM
BURKE WILLIAM W	Director	May 08 '25	Sale	9.67	3,300	31,911	48,520	May 09 04:28 PM
Dodd Sheri Louise	Director	May 08 '25	Proposed Sale	9.83	3,149	30,955		May 08 07:17 PM
BURKE WILLIAM W	Director	May 08 '25	Proposed Sale	9.67	3,300	31,911		May 08 04:46 PM
Ferstler Sherri Lee	Officer	Apr 03 '25	Proposed Sale	13.14	2,355	30,945		Apr 03 05:30 PM
Birkemeyer Elaine M.	Chief Financial Officer	Feb 25 '25	Sale	14.51	2,066	29,980	102,032	Feb 27 04:29 PM
Burns Kristie	Sr. VP Mktg & Clinical Affairs	Feb 25 '25	Sale	14.40	6,468	93,160	77,540	Feb 27 04:28 PM
REUVERS DANIEL L.	Director	Feb 25 '25	Sale	14.18	28,338	401,850	214,604	Feb 27 04:27 PM
REUVERS DANIEL L.	Officer	Feb 25 '25	Proposed Sale	14.18	28,338	401,851		Feb 25 07:35 PM
Burns Kristie	Officer	Feb 25 '25	Proposed Sale	14.40	6,468	93,160		Feb 25 07:15 PM
Birkemeyer Elaine M.	Officer	Feb 25 '25	Proposed Sale	14.51	2,066	29,980		Feb 25 06:54 PM
REUVERS DANIEL L.	Director	Feb 24 '25	Sale	14.55	10,938	159,147	242,942	Feb 24 06:24 PM
Burns Kristie	Sr. VP Mktg & Clinical Affairs	Feb 24 '25	Sale	14.65	4,830	70,753	84,008	Feb 24 06:23 PM
Birkemeyer Elaine M.	Chief Financial Officer	Feb 24 '25	Sale	14.70	3,778	55,538	104,098	Feb 24 06:22 PM
REUVERS DANIEL L.	Officer	Feb 24 '25	Proposed Sale	14.55	10,938	159,147		Feb 24 05:23 PM
Burns Kristie	Officer	Feb 24 '25	Proposed Sale	14.65	4,830	70,753		Feb 24 05:12 PM
Ferstler Sherri Lee	Officer	Feb 24 '25	Proposed Sale	14.79	2,209	32,660		Feb 24 04:58 PM
Birkemeyer Elaine M.	Officer	Feb 24 '25	Proposed Sale	14.70	3,778	55,538		Feb 24 04:55 PM

CBLL

Ceribell Inc

ATGE

Adtalem Global Education Inc

TCMD

Tactile Systems Technology Inc

Upgrade your FINVIZ experience